| 000 | 01894 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516052309.0 | ||
| 264 | 0 | _c20120229 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1437-4331 | ||
| 024 | 7 |
_a10.1515/CCLM.2011.678 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOláh, Anna V | |
| 245 | 0 | 0 |
_aMonitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy. _h[electronic resource] |
| 260 |
_bClinical chemistry and laboratory medicine _cNov 2011 |
||
| 300 |
_a1849-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetylglucosaminidase _xanalysis |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBiological Assay |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Rejection _xdrug therapy |
| 650 | 0 | 4 |
_aGraft Survival _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney _ximmunology |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycophenolic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 700 | 1 | _aAsztalos, László | |
| 700 | 1 | _aIvády, Gergely | |
| 700 | 1 | _aVarga, Eva | |
| 700 | 1 | _aKovács, Agota M | |
| 700 | 1 | _aKappelmayer, János | |
| 700 | 1 | _aVarga, József | |
| 773 | 0 |
_tClinical chemistry and laboratory medicine _gvol. 49 _gno. 11 _gp. 1849-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1515/CCLM.2011.678 _zAvailable from publisher's website |
| 999 |
_c21092129 _d21092129 |
||